Tetra Discovery Partners suggested that people interested in the Chicago clinical trial visit their website and request more information for the clinical trial. The trial is for a drug that pertains to Fragile X but the same drug is believed to have benefits for RTS as well. As such, Tetra is open to having a separate trial for RTS patients.
Testing drug called BPN14770, which has been passed safety tests on healthy volunteer and acts as a selective PDE4D inhibitor.
Remember, you should be able to visit Chicago on three intervals in six months and should be aged 18-45.
For registration please fill in this form: http://tetradiscovery.com/clinical-trials/ .